CVS Health (NYSE:CVS) Shares Down 0.2%

CVS Health Co. (NYSE:CVSGet Free Report)’s stock price was down 0.2% on Monday . The company traded as low as $55.53 and last traded at $55.54. Approximately 11,725,700 shares were traded during mid-day trading, a decline of 2% from the average daily volume of 12,009,923 shares. The stock had previously closed at $55.65.

Analyst Upgrades and Downgrades

A number of equities analysts recently weighed in on CVS shares. StockNews.com lowered CVS Health from a “buy” rating to a “hold” rating in a research report on Thursday, February 15th. UBS Group lowered CVS Health from a “buy” rating to a “neutral” rating and decreased their price target for the company from $85.00 to $60.00 in a research report on Thursday, May 2nd. Leerink Partnrs lowered CVS Health from an “outperform” rating to a “market perform” rating in a research report on Wednesday, May 1st. Bank of America decreased their price target on CVS Health from $95.00 to $77.00 and set a “buy” rating for the company in a research report on Thursday, May 2nd. Finally, The Goldman Sachs Group reduced their price objective on CVS Health from $85.00 to $74.00 and set a “buy” rating for the company in a research note on Thursday, May 2nd. Nine equities research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $76.75.

View Our Latest Research Report on CVS

CVS Health Price Performance

The stock has a 50 day moving average price of $66.20 and a two-hundred day moving average price of $71.77. The company has a debt-to-equity ratio of 0.78, a quick ratio of 0.61 and a current ratio of 0.81. The company has a market capitalization of $67.33 billion, a PE ratio of 9.43, a P/E/G ratio of 0.53 and a beta of 0.56.

CVS Health (NYSE:CVSGet Free Report) last issued its quarterly earnings data on Wednesday, May 1st. The pharmacy operator reported $1.31 earnings per share for the quarter, missing analysts’ consensus estimates of $1.69 by ($0.38). CVS Health had a net margin of 2.03% and a return on equity of 13.53%. The company had revenue of $88.44 billion during the quarter, compared to the consensus estimate of $89.33 billion. During the same period in the previous year, the business posted $2.20 earnings per share. The firm’s revenue was up 3.7% on a year-over-year basis. Equities analysts forecast that CVS Health Co. will post 7.02 earnings per share for the current year.

CVS Health Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, May 1st. Investors of record on Monday, April 22nd were paid a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.96%. The ex-dividend date of this dividend was Friday, April 19th. CVS Health’s payout ratio is 46.75%.

Insider Activity at CVS Health

In other CVS Health news, Director Edward J. Ludwig bought 1,000 shares of the stock in a transaction on Thursday, May 2nd. The shares were purchased at an average price of $53.88 per share, with a total value of $53,880.00. Following the acquisition, the director now directly owns 21,630 shares of the company’s stock, valued at approximately $1,165,424.40. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. 0.24% of the stock is owned by company insiders.

Institutional Trading of CVS Health

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Atticus Wealth Management LLC grew its holdings in CVS Health by 149.0% in the 4th quarter. Atticus Wealth Management LLC now owns 366 shares of the pharmacy operator’s stock valued at $29,000 after buying an additional 219 shares during the last quarter. USA Financial Formulas grew its holdings in shares of CVS Health by 573.2% during the 4th quarter. USA Financial Formulas now owns 377 shares of the pharmacy operator’s stock worth $30,000 after purchasing an additional 321 shares in the last quarter. Ables Iannone Moore & Associates Inc. acquired a new stake in shares of CVS Health during the 4th quarter worth approximately $32,000. Creekmur Asset Management LLC acquired a new stake in shares of CVS Health during the 4th quarter worth approximately $34,000. Finally, Steph & Co. grew its holdings in shares of CVS Health by 192.0% during the 1st quarter. Steph & Co. now owns 438 shares of the pharmacy operator’s stock worth $35,000 after purchasing an additional 288 shares in the last quarter. Institutional investors and hedge funds own 80.66% of the company’s stock.

CVS Health Company Profile

(Get Free Report)

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.

Read More

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.